Neuralink reports that the FDA has approved a human clinical trial

Neuralink reports that the FDA has approved a human clinical trial

The Link, a brain implant being developed by Neuralink, intends to enable individuals with severe paralysis to operate external technology only utilizing neural impulses.

Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study.

Neuralink is building a brain implant called the Link, which aims to help patients with severe paralysis control external technologies using only neural signals. This means patients with severe degenerative diseases like ALS could eventually regain their ability to communicate with loved ones by moving cursors and typing with their minds.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company wrote in a tweet.

The FDA and Neuralink did not immediately respond to CNBC’s request for comment. The extent of the approved trial is not known. Neuralink said in a tweet that patient recruitment for its clinical trial is not open yet.

Neuralink is part of the emerging brain-computer interface, or BCI, industry. A BCI is a system that deciphers brain signals and translates them into commands for external technologies. Neuralink is perhaps the best-known name in the space thanks to the high profile of Musk, who is also the CEO of Tesla, SpaceX and Twitter.

Scientists have been studying BCI technology for decades, and several companies have developed promising systems that they hope to bring to market. But receiving FDA approval for a commercial medical device is no small task — it requires companies to successfully conduct several extremely thorough rounds of testing and data safety collection.

No BCI company has managed to clinch the FDA’s final seal of approval. But by receiving the go-ahead for a study with human patients, Neuralink is one step closer to market.

Neuralink’s BCI will require patients to undergo invasive brain surgery. Its system centers around the Link, a small circular implant that processes and translates neural signals. The Link is connected to a series of thin, flexible threads inserted directly into the brain tissue where they detect neural signals.

Patients with Neuralink devices will learn to control it using the Neuralink app. Patients will then be able to control external mice and keyboards through a Bluetooth connection, according to the company’s website.

The FDA’s approval for an in-human study is a significant win for Neuralink after a series of recent hurdles at the company. In February, the U.S. Department of Transportation confirmed to CNBC that it had opened an investigation into Neuralink for allegedly packaging and transporting contaminated hardware in an unsafe manner. Reuters reported in March that the FDA had rejected Neuralink’s application for human trials, and reportedly outlined “dozens” of issues the company needed to address.

Neuralink has also come under fire from activist groups for its alleged treatment of animals. The Physician’s Committee for Responsible Medicine, which advocates against animal testing, has repeatedly called on Musk to release details about experiments on monkeys that had resulted in internal bleeding, paralysis, chronic infections, seizures, declining psychological health and death.

A representative for PCRM did not immediately respond to CNBC’s request for comment.

In addition to helping patients with paralysis, experts believe BCIs could someday help treat maladies like blindness and mental illness. Musk has expressed his intent for Neuralink to explore these future use cases, as well as potential applications for healthy people.

At a “show and tell” recruitment event late last year, Musk even claimed he plans to someday receive one of Neuralink’s implants himself.

“You could have a Neuralink device implanted right now and you wouldn’t even know,” Musk said at the time. “In fact, in one of these demos, I will.”

 

Source: CNBC.com

Related Posts
Elon Musk’s Neuralink is under investigation
Neuralink, the medical device company owned by Elon Musk, is under investigation from a federal
Tesla expands its operations globally as the ground breaking outside U.S. occurs for the first time
There was ground breaking in Shanghai as Tesla Owner Elon Musk has decided to open
GOP to engage in intraparty conflict on Ukraine in the House and Senate
Republicans in the Senate and the House are preparing for an internal conflict over President
As Tropical Storm Franklin approaches the Texas coast, Haiti and the Dominican Republic prepare
Authorities in Haiti and the Dominican Republic issued warnings to citizens to get ready for
Teenagers in US tend to drive much less nowadays
Teenagers in America appear to be delaying driving more than ever. According to the Federal
Midwest once more covered with smoke from Canadian wildfires
Wildfires in Canada are once more aiming at the Midwest's air quality as the area
Democrats and Unions to sign a labor peace agreement
Unions and national Democrats are set to sign a labor peace agreement this week for
Memorandum of understanding paves the way for gigafactory in Kokomo
Stellantis NV and Samsung SDI announced on Monday that they have signed a memorandum of
Arkansas counties to implement crypto mining noise reduction regulations
Several counties in Arkansas are rushing to implement new regulations by August, when cryptomining facilities
FlightAware: more than 10,000 flights canceled or delayed
On Sunday, more than 2,600 flights were canceled and nearly 7,900 were delayed in the